EcoDrugPlus

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSONIG00000003320
Gene Symbol: RPTOR
3 Cross references
213 Possible Orthologues:

Renin

Ensembl ID : ENSONIG00000017285
Gene Symbol: LOC100691504
4 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSONIG00000010322
Gene Symbol: RET
4 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSONIG00000010320
Gene Symbol: RARB
1 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSONIG00000006493
Gene Symbol: LOC100698153
3 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSONIG00000012223
Gene Symbol: RARG
4 Cross references
325 Possible Orthologues:

Retinoic Acid Receptor Gamma-A

Ensembl ID : ENSONIG00000019165
Gene Symbol: LOC100707970
4 Cross references
373 Possible Orthologues:

Rho-Associated Protein Kinase 2

Ensembl ID : ENSONIG00000014677
Gene Symbol: LOC100701417
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSONIG00000011864
Gene Symbol: RPL10A
4 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSONIG00000017753
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSONIG00000003387
Gene Symbol: RPL12
1 Cross references
431 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSONIG00000005934
Gene Symbol: RPL13
4 Cross references
275 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).